Author： Friebe U.W-G.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.3, 1997-03, pp. : 279-298
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phospholipase A2 inhibitors in inflammation
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. :
Access to resources
Recommend
Phospholipase A2 inhibitors promising in CHD
Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. :
The therapeutic potential for phospholipase A2 inhibitors
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Potential therapeutic uses of phospholipase A2 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. :
Phospholipase A2 Inhibitors as Potential Anti-Inflammatory Agents
Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. :